As families gather for Thanksgiving, here's what to know to protect your family from the new subclade K flu strain.

The deal, one of two multibillion-dollar buyouts from Merck this year, centers around a drug that could become an alternative ...

Merck & Co. is spending $9.2 billion for Cidara Therapeutics and its lead influenza antiviral that was dropped by Johnson & ...

MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

HOUSTON – Houston might still feel like summer, but flu season isn’t waiting for temperatures to fall in line. Doctors say ...

Infectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses spread rapidly because of changing climates, crowded cities, and increased ...

Even though this flu season has been severe and the use of antiviral medication can help keep some people out of the hospital or out of the intensive care unit, such drugs are being underutilized by ...

Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to ...

Expert Rev Pharmacoeconomics Outcomes Res. 2008;8(6):563-573. Influenza is responsible for a great number of cases each year and, consequently, high healthcare costs. Influenza vaccination is the ...

Background The large-scale deployment of antiviral drugs from the Strategic National Stockpile during the 2009 H1N1 influenza response provides a unique opportunity to study local public health ...